nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CHRM3—Amitriptyline—migraine	0.178	0.279	CbGbCtD
Dicyclomine—CYP1A1—Propranolol—migraine	0.163	0.256	CbGbCtD
Dicyclomine—CHRM1—Amitriptyline—migraine	0.155	0.242	CbGbCtD
Dicyclomine—CHRM2—Amitriptyline—migraine	0.143	0.223	CbGbCtD
Dicyclomine—Hypoaesthesia—Valproic Acid—migraine	0.000602	0.00238	CcSEcCtD
Dicyclomine—Hallucination—Valproic Acid—migraine	0.000602	0.00238	CcSEcCtD
Dicyclomine—Affect lability—Topiramate—migraine	0.000601	0.00237	CcSEcCtD
Dicyclomine—Shock—Verapamil—migraine	0.000597	0.00235	CcSEcCtD
Dicyclomine—Insomnia—Propranolol—migraine	0.000596	0.00235	CcSEcCtD
Dicyclomine—Paraesthesia—Propranolol—migraine	0.000592	0.00234	CcSEcCtD
Dicyclomine—Tachycardia—Verapamil—migraine	0.000592	0.00233	CcSEcCtD
Dicyclomine—Face oedema—Topiramate—migraine	0.000589	0.00232	CcSEcCtD
Dicyclomine—Dyspnoea—Propranolol—migraine	0.000588	0.00232	CcSEcCtD
Dicyclomine—Somnolence—Propranolol—migraine	0.000586	0.00231	CcSEcCtD
Dicyclomine—Asthenia—Amitriptyline—migraine	0.000581	0.00229	CcSEcCtD
Dicyclomine—Dyspepsia—Propranolol—migraine	0.00058	0.00229	CcSEcCtD
Dicyclomine—Urinary retention—Topiramate—migraine	0.00058	0.00229	CcSEcCtD
Dicyclomine—Mood swings—Topiramate—migraine	0.000578	0.00228	CcSEcCtD
Dicyclomine—Erectile dysfunction—Gabapentin—migraine	0.000577	0.00228	CcSEcCtD
Dicyclomine—Decreased appetite—Propranolol—migraine	0.000573	0.00226	CcSEcCtD
Dicyclomine—Pruritus—Amitriptyline—migraine	0.000573	0.00226	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Propranolol—migraine	0.000569	0.00225	CcSEcCtD
Dicyclomine—Fatigue—Propranolol—migraine	0.000568	0.00224	CcSEcCtD
Dicyclomine—Eye disorder—Valproic Acid—migraine	0.000566	0.00223	CcSEcCtD
Dicyclomine—Pain—Propranolol—migraine	0.000564	0.00222	CcSEcCtD
Dicyclomine—Constipation—Propranolol—migraine	0.000564	0.00222	CcSEcCtD
Dicyclomine—Drowsiness—Gabapentin—migraine	0.000559	0.0022	CcSEcCtD
Dicyclomine—Breast disorder—Topiramate—migraine	0.000551	0.00218	CcSEcCtD
Dicyclomine—Insomnia—Verapamil—migraine	0.000548	0.00216	CcSEcCtD
Dicyclomine—Immune system disorder—Valproic Acid—migraine	0.000547	0.00216	CcSEcCtD
Dicyclomine—Mediastinal disorder—Valproic Acid—migraine	0.000545	0.00215	CcSEcCtD
Dicyclomine—Paraesthesia—Verapamil—migraine	0.000545	0.00215	CcSEcCtD
Dicyclomine—Dyspnoea—Verapamil—migraine	0.000541	0.00213	CcSEcCtD
Dicyclomine—Somnolence—Verapamil—migraine	0.000539	0.00213	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Propranolol—migraine	0.000539	0.00213	CcSEcCtD
Dicyclomine—Muscular weakness—Topiramate—migraine	0.000538	0.00212	CcSEcCtD
Dicyclomine—Hallucination—Timolol—migraine	0.000536	0.00211	CcSEcCtD
Dicyclomine—Dizziness—Amitriptyline—migraine	0.000535	0.00211	CcSEcCtD
Dicyclomine—Dyspepsia—Verapamil—migraine	0.000534	0.00211	CcSEcCtD
Dicyclomine—Abdominal distension—Topiramate—migraine	0.000531	0.00209	CcSEcCtD
Dicyclomine—Mental disorder—Valproic Acid—migraine	0.00053	0.00209	CcSEcCtD
Dicyclomine—Urticaria—Propranolol—migraine	0.000524	0.00207	CcSEcCtD
Dicyclomine—Fatigue—Verapamil—migraine	0.000523	0.00206	CcSEcCtD
Dicyclomine—Abdominal pain—Propranolol—migraine	0.000521	0.00206	CcSEcCtD
Dicyclomine—Constipation—Verapamil—migraine	0.000519	0.00205	CcSEcCtD
Dicyclomine—Pain—Verapamil—migraine	0.000519	0.00205	CcSEcCtD
Dicyclomine—Tension—Valproic Acid—migraine	0.000517	0.00204	CcSEcCtD
Dicyclomine—Vomiting—Amitriptyline—migraine	0.000515	0.00203	CcSEcCtD
Dicyclomine—Nervousness—Valproic Acid—migraine	0.000512	0.00202	CcSEcCtD
Dicyclomine—Rash—Amitriptyline—migraine	0.00051	0.00201	CcSEcCtD
Dicyclomine—Dermatitis—Amitriptyline—migraine	0.00051	0.00201	CcSEcCtD
Dicyclomine—Headache—Amitriptyline—migraine	0.000507	0.002	CcSEcCtD
Dicyclomine—Eye disorder—Timolol—migraine	0.000503	0.00199	CcSEcCtD
Dicyclomine—Cardiac disorder—Timolol—migraine	0.0005	0.00197	CcSEcCtD
Dicyclomine—Feeling abnormal—Verapamil—migraine	0.0005	0.00197	CcSEcCtD
Dicyclomine—Hallucination—Gabapentin—migraine	0.000499	0.00197	CcSEcCtD
Dicyclomine—Hypoaesthesia—Gabapentin—migraine	0.000499	0.00197	CcSEcCtD
Dicyclomine—Vision blurred—Valproic Acid—migraine	0.000496	0.00196	CcSEcCtD
Dicyclomine—Ill-defined disorder—Valproic Acid—migraine	0.000489	0.00193	CcSEcCtD
Dicyclomine—Immune system disorder—Timolol—migraine	0.000487	0.00192	CcSEcCtD
Dicyclomine—Hypersensitivity—Propranolol—migraine	0.000486	0.00192	CcSEcCtD
Dicyclomine—Erectile dysfunction—Topiramate—migraine	0.000486	0.00192	CcSEcCtD
Dicyclomine—Mediastinal disorder—Timolol—migraine	0.000486	0.00192	CcSEcCtD
Dicyclomine—Agitation—Valproic Acid—migraine	0.000484	0.00191	CcSEcCtD
Dicyclomine—Urticaria—Verapamil—migraine	0.000482	0.0019	CcSEcCtD
Dicyclomine—Angioedema—Valproic Acid—migraine	0.000481	0.0019	CcSEcCtD
Dicyclomine—Nausea—Amitriptyline—migraine	0.000481	0.0019	CcSEcCtD
Dicyclomine—Malaise—Valproic Acid—migraine	0.000475	0.00187	CcSEcCtD
Dicyclomine—Asthenia—Propranolol—migraine	0.000473	0.00187	CcSEcCtD
Dicyclomine—Mental disorder—Timolol—migraine	0.000472	0.00186	CcSEcCtD
Dicyclomine—Erythema—Timolol—migraine	0.000469	0.00185	CcSEcCtD
Dicyclomine—Eye disorder—Gabapentin—migraine	0.000469	0.00185	CcSEcCtD
Dicyclomine—Cardiac disorder—Gabapentin—migraine	0.000466	0.00184	CcSEcCtD
Dicyclomine—Palpitations—Valproic Acid—migraine	0.000466	0.00184	CcSEcCtD
Dicyclomine—Tension—Timolol—migraine	0.00046	0.00182	CcSEcCtD
Dicyclomine—Nervousness—Timolol—migraine	0.000455	0.0018	CcSEcCtD
Dicyclomine—Hypertension—Valproic Acid—migraine	0.000455	0.00179	CcSEcCtD
Dicyclomine—Immune system disorder—Gabapentin—migraine	0.000453	0.00179	CcSEcCtD
Dicyclomine—Mediastinal disorder—Gabapentin—migraine	0.000452	0.00178	CcSEcCtD
Dicyclomine—Hypersensitivity—Verapamil—migraine	0.000447	0.00176	CcSEcCtD
Dicyclomine—Discomfort—Valproic Acid—migraine	0.000443	0.00175	CcSEcCtD
Dicyclomine—Vision blurred—Timolol—migraine	0.000442	0.00174	CcSEcCtD
Dicyclomine—Mental disorder—Gabapentin—migraine	0.00044	0.00173	CcSEcCtD
Dicyclomine—Dry mouth—Valproic Acid—migraine	0.000439	0.00173	CcSEcCtD
Dicyclomine—Erythema—Gabapentin—migraine	0.000437	0.00172	CcSEcCtD
Dicyclomine—Dizziness—Propranolol—migraine	0.000436	0.00172	CcSEcCtD
Dicyclomine—Asthenia—Verapamil—migraine	0.000435	0.00172	CcSEcCtD
Dicyclomine—Confusional state—Valproic Acid—migraine	0.000434	0.00171	CcSEcCtD
Dicyclomine—Oedema—Valproic Acid—migraine	0.00043	0.0017	CcSEcCtD
Dicyclomine—Anaphylactic shock—Valproic Acid—migraine	0.00043	0.0017	CcSEcCtD
Dicyclomine—Pruritus—Verapamil—migraine	0.000429	0.00169	CcSEcCtD
Dicyclomine—Tension—Gabapentin—migraine	0.000429	0.00169	CcSEcCtD
Dicyclomine—Angioedema—Timolol—migraine	0.000429	0.00169	CcSEcCtD
Dicyclomine—Nervousness—Gabapentin—migraine	0.000424	0.00167	CcSEcCtD
Dicyclomine—Nervous system disorder—Valproic Acid—migraine	0.000422	0.00166	CcSEcCtD
Dicyclomine—Syncope—Timolol—migraine	0.000421	0.00166	CcSEcCtD
Dicyclomine—Hypoaesthesia—Topiramate—migraine	0.00042	0.00166	CcSEcCtD
Dicyclomine—Hallucination—Topiramate—migraine	0.00042	0.00166	CcSEcCtD
Dicyclomine—Tachycardia—Valproic Acid—migraine	0.00042	0.00166	CcSEcCtD
Dicyclomine—Vomiting—Propranolol—migraine	0.000419	0.00165	CcSEcCtD
Dicyclomine—Rash—Propranolol—migraine	0.000416	0.00164	CcSEcCtD
Dicyclomine—Dermatitis—Propranolol—migraine	0.000415	0.00164	CcSEcCtD
Dicyclomine—Palpitations—Timolol—migraine	0.000414	0.00164	CcSEcCtD
Dicyclomine—Loss of consciousness—Timolol—migraine	0.000412	0.00163	CcSEcCtD
Dicyclomine—Vision blurred—Gabapentin—migraine	0.000412	0.00162	CcSEcCtD
Dicyclomine—Anorexia—Valproic Acid—migraine	0.00041	0.00162	CcSEcCtD
Dicyclomine—Ill-defined disorder—Gabapentin—migraine	0.000405	0.0016	CcSEcCtD
Dicyclomine—Hypertension—Timolol—migraine	0.000405	0.0016	CcSEcCtD
Dicyclomine—Agitation—Gabapentin—migraine	0.000401	0.00158	CcSEcCtD
Dicyclomine—Dizziness—Verapamil—migraine	0.000401	0.00158	CcSEcCtD
Dicyclomine—Angioedema—Gabapentin—migraine	0.000399	0.00157	CcSEcCtD
Dicyclomine—Discomfort—Timolol—migraine	0.000394	0.00156	CcSEcCtD
Dicyclomine—Eye disorder—Topiramate—migraine	0.000394	0.00156	CcSEcCtD
Dicyclomine—Malaise—Gabapentin—migraine	0.000394	0.00155	CcSEcCtD
Dicyclomine—Cardiac disorder—Topiramate—migraine	0.000392	0.00155	CcSEcCtD
Dicyclomine—Syncope—Gabapentin—migraine	0.000392	0.00155	CcSEcCtD
Dicyclomine—Nausea—Propranolol—migraine	0.000392	0.00154	CcSEcCtD
Dicyclomine—Dry mouth—Timolol—migraine	0.00039	0.00154	CcSEcCtD
Dicyclomine—Insomnia—Valproic Acid—migraine	0.000389	0.00153	CcSEcCtD
Dicyclomine—Paraesthesia—Valproic Acid—migraine	0.000386	0.00152	CcSEcCtD
Dicyclomine—Palpitations—Gabapentin—migraine	0.000386	0.00152	CcSEcCtD
Dicyclomine—Confusional state—Timolol—migraine	0.000386	0.00152	CcSEcCtD
Dicyclomine—Vomiting—Verapamil—migraine	0.000386	0.00152	CcSEcCtD
Dicyclomine—Loss of consciousness—Gabapentin—migraine	0.000384	0.00151	CcSEcCtD
Dicyclomine—Dyspnoea—Valproic Acid—migraine	0.000383	0.00151	CcSEcCtD
Dicyclomine—Anaphylactic shock—Timolol—migraine	0.000383	0.00151	CcSEcCtD
Dicyclomine—Oedema—Timolol—migraine	0.000383	0.00151	CcSEcCtD
Dicyclomine—Rash—Verapamil—migraine	0.000382	0.00151	CcSEcCtD
Dicyclomine—Somnolence—Valproic Acid—migraine	0.000382	0.00151	CcSEcCtD
Dicyclomine—Dermatitis—Verapamil—migraine	0.000382	0.00151	CcSEcCtD
Dicyclomine—Immune system disorder—Topiramate—migraine	0.000381	0.0015	CcSEcCtD
Dicyclomine—Mediastinal disorder—Topiramate—migraine	0.00038	0.0015	CcSEcCtD
Dicyclomine—Headache—Verapamil—migraine	0.00038	0.0015	CcSEcCtD
Dicyclomine—Dyspepsia—Valproic Acid—migraine	0.000378	0.00149	CcSEcCtD
Dicyclomine—Hypertension—Gabapentin—migraine	0.000377	0.00149	CcSEcCtD
Dicyclomine—Shock—Timolol—migraine	0.000377	0.00149	CcSEcCtD
Dicyclomine—Nervous system disorder—Timolol—migraine	0.000375	0.00148	CcSEcCtD
Dicyclomine—Decreased appetite—Valproic Acid—migraine	0.000374	0.00147	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Valproic Acid—migraine	0.000371	0.00146	CcSEcCtD
Dicyclomine—Fatigue—Valproic Acid—migraine	0.000371	0.00146	CcSEcCtD
Dicyclomine—Mental disorder—Topiramate—migraine	0.00037	0.00146	CcSEcCtD
Dicyclomine—Constipation—Valproic Acid—migraine	0.000368	0.00145	CcSEcCtD
Dicyclomine—Pain—Valproic Acid—migraine	0.000368	0.00145	CcSEcCtD
Dicyclomine—Erythema—Topiramate—migraine	0.000367	0.00145	CcSEcCtD
Dicyclomine—Discomfort—Gabapentin—migraine	0.000367	0.00145	CcSEcCtD
Dicyclomine—Anorexia—Timolol—migraine	0.000365	0.00144	CcSEcCtD
Dicyclomine—Dry mouth—Gabapentin—migraine	0.000364	0.00143	CcSEcCtD
Dicyclomine—Tension—Topiramate—migraine	0.000361	0.00142	CcSEcCtD
Dicyclomine—Nausea—Verapamil—migraine	0.00036	0.00142	CcSEcCtD
Dicyclomine—Confusional state—Gabapentin—migraine	0.000359	0.00142	CcSEcCtD
Dicyclomine—Nervousness—Topiramate—migraine	0.000357	0.00141	CcSEcCtD
Dicyclomine—Anaphylactic shock—Gabapentin—migraine	0.000356	0.00141	CcSEcCtD
Dicyclomine—Oedema—Gabapentin—migraine	0.000356	0.00141	CcSEcCtD
Dicyclomine—Feeling abnormal—Valproic Acid—migraine	0.000354	0.0014	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Valproic Acid—migraine	0.000352	0.00139	CcSEcCtD
Dicyclomine—Shock—Gabapentin—migraine	0.000351	0.00138	CcSEcCtD
Dicyclomine—Nervous system disorder—Gabapentin—migraine	0.00035	0.00138	CcSEcCtD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000349	0.00323	CbGpPWpGaD
Dicyclomine—Tachycardia—Gabapentin—migraine	0.000348	0.00137	CcSEcCtD
Dicyclomine—Vision blurred—Topiramate—migraine	0.000346	0.00137	CcSEcCtD
Dicyclomine—Insomnia—Timolol—migraine	0.000346	0.00137	CcSEcCtD
Dicyclomine—Paraesthesia—Timolol—migraine	0.000344	0.00136	CcSEcCtD
Dicyclomine—Urticaria—Valproic Acid—migraine	0.000342	0.00135	CcSEcCtD
Dicyclomine—Dyspnoea—Timolol—migraine	0.000341	0.00135	CcSEcCtD
Dicyclomine—Ill-defined disorder—Topiramate—migraine	0.000341	0.00134	CcSEcCtD
Dicyclomine—Somnolence—Timolol—migraine	0.00034	0.00134	CcSEcCtD
Dicyclomine—Abdominal pain—Valproic Acid—migraine	0.00034	0.00134	CcSEcCtD
Dicyclomine—Anorexia—Gabapentin—migraine	0.00034	0.00134	CcSEcCtD
Dicyclomine—Agitation—Topiramate—migraine	0.000338	0.00133	CcSEcCtD
Dicyclomine—Dyspepsia—Timolol—migraine	0.000337	0.00133	CcSEcCtD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000334	0.00309	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000333	0.00308	CbGpPWpGaD
Dicyclomine—Decreased appetite—Timolol—migraine	0.000333	0.00131	CcSEcCtD
Dicyclomine—CHRM3—GPCRs, Other—HTR2A—migraine	0.000332	0.00308	CbGpPWpGaD
Dicyclomine—Malaise—Topiramate—migraine	0.000331	0.00131	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Timolol—migraine	0.00033	0.0013	CcSEcCtD
Dicyclomine—Fatigue—Timolol—migraine	0.00033	0.0013	CcSEcCtD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00033	0.00305	CbGpPWpGaD
Dicyclomine—Syncope—Topiramate—migraine	0.000329	0.0013	CcSEcCtD
Dicyclomine—CHRM2—GPCRs, Other—HTR2A—migraine	0.000329	0.00305	CbGpPWpGaD
Dicyclomine—Pain—Timolol—migraine	0.000327	0.00129	CcSEcCtD
Dicyclomine—Palpitations—Topiramate—migraine	0.000325	0.00128	CcSEcCtD
Dicyclomine—Loss of consciousness—Topiramate—migraine	0.000323	0.00127	CcSEcCtD
Dicyclomine—Insomnia—Gabapentin—migraine	0.000322	0.00127	CcSEcCtD
Dicyclomine—Paraesthesia—Gabapentin—migraine	0.00032	0.00126	CcSEcCtD
Dicyclomine—Dyspnoea—Gabapentin—migraine	0.000318	0.00125	CcSEcCtD
Dicyclomine—Hypertension—Topiramate—migraine	0.000317	0.00125	CcSEcCtD
Dicyclomine—Somnolence—Gabapentin—migraine	0.000317	0.00125	CcSEcCtD
Dicyclomine—Hypersensitivity—Valproic Acid—migraine	0.000317	0.00125	CcSEcCtD
Dicyclomine—Feeling abnormal—Timolol—migraine	0.000315	0.00124	CcSEcCtD
Dicyclomine—Dyspepsia—Gabapentin—migraine	0.000314	0.00124	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Timolol—migraine	0.000313	0.00123	CcSEcCtD
Dicyclomine—CHRM1—G alpha (q) signalling events—TAC1—migraine	0.000311	0.00289	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—NPS—migraine	0.000311	0.00289	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—NPS—migraine	0.00031	0.00288	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—TAC1—migraine	0.00031	0.00288	CbGpPWpGaD
Dicyclomine—Decreased appetite—Gabapentin—migraine	0.00031	0.00122	CcSEcCtD
Dicyclomine—Discomfort—Topiramate—migraine	0.000309	0.00122	CcSEcCtD
Dicyclomine—Asthenia—Valproic Acid—migraine	0.000308	0.00122	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Gabapentin—migraine	0.000308	0.00121	CcSEcCtD
Dicyclomine—Fatigue—Gabapentin—migraine	0.000307	0.00121	CcSEcCtD
Dicyclomine—Dry mouth—Topiramate—migraine	0.000306	0.00121	CcSEcCtD
Dicyclomine—CHRM1—G alpha (q) signalling events—HTR2C—migraine	0.000305	0.00283	CbGpPWpGaD
Dicyclomine—Constipation—Gabapentin—migraine	0.000305	0.0012	CcSEcCtD
Dicyclomine—Pain—Gabapentin—migraine	0.000305	0.0012	CcSEcCtD
Dicyclomine—CHRM3—G alpha (q) signalling events—HTR2C—migraine	0.000304	0.00282	CbGpPWpGaD
Dicyclomine—Pruritus—Valproic Acid—migraine	0.000304	0.0012	CcSEcCtD
Dicyclomine—Urticaria—Timolol—migraine	0.000304	0.0012	CcSEcCtD
Dicyclomine—Abdominal pain—Timolol—migraine	0.000303	0.00119	CcSEcCtD
Dicyclomine—Confusional state—Topiramate—migraine	0.000302	0.00119	CcSEcCtD
Dicyclomine—Oedema—Topiramate—migraine	0.0003	0.00118	CcSEcCtD
Dicyclomine—CHRM1—G alpha (q) signalling events—EDNRA—migraine	0.000297	0.00275	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—EDNRA—migraine	0.000296	0.00274	CbGpPWpGaD
Dicyclomine—Shock—Topiramate—migraine	0.000295	0.00116	CcSEcCtD
Dicyclomine—Nervous system disorder—Topiramate—migraine	0.000294	0.00116	CcSEcCtD
Dicyclomine—CHRM1—Circadian rythm related genes—NPS—migraine	0.000294	0.00272	CbGpPWpGaD
Dicyclomine—Feeling abnormal—Gabapentin—migraine	0.000294	0.00116	CcSEcCtD
Dicyclomine—Tachycardia—Topiramate—migraine	0.000293	0.00115	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Gabapentin—migraine	0.000291	0.00115	CcSEcCtD
Dicyclomine—CHRM1—Circadian rythm related genes—SLC6A4—migraine	0.000288	0.00267	CbGpPWpGaD
Dicyclomine—Anorexia—Topiramate—migraine	0.000286	0.00113	CcSEcCtD
Dicyclomine—Dizziness—Valproic Acid—migraine	0.000284	0.00112	CcSEcCtD
Dicyclomine—Urticaria—Gabapentin—migraine	0.000283	0.00112	CcSEcCtD
Dicyclomine—Hypersensitivity—Timolol—migraine	0.000282	0.00111	CcSEcCtD
Dicyclomine—Abdominal pain—Gabapentin—migraine	0.000282	0.00111	CcSEcCtD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000279	0.00258	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000279	0.00258	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000278	0.00257	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000278	0.00257	CbGpPWpGaD
Dicyclomine—Asthenia—Timolol—migraine	0.000275	0.00108	CcSEcCtD
Dicyclomine—CHRM1—GPCR ligand binding—HTR1D—migraine	0.000273	0.00253	CbGpPWpGaD
Dicyclomine—Vomiting—Valproic Acid—migraine	0.000273	0.00108	CcSEcCtD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000273	0.00253	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR1D—migraine	0.000273	0.00253	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000272	0.00252	CbGpPWpGaD
Dicyclomine—Insomnia—Topiramate—migraine	0.000271	0.00107	CcSEcCtD
Dicyclomine—Rash—Valproic Acid—migraine	0.000271	0.00107	CcSEcCtD
Dicyclomine—Dermatitis—Valproic Acid—migraine	0.000271	0.00107	CcSEcCtD
Dicyclomine—Pruritus—Timolol—migraine	0.000271	0.00107	CcSEcCtD
Dicyclomine—CHRM2—G alpha (i) signalling events—HTR1B—migraine	0.00027	0.0025	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HTR1D—migraine	0.00027	0.0025	CbGpPWpGaD
Dicyclomine—Headache—Valproic Acid—migraine	0.000269	0.00106	CcSEcCtD
Dicyclomine—Paraesthesia—Topiramate—migraine	0.000269	0.00106	CcSEcCtD
Dicyclomine—Dyspnoea—Topiramate—migraine	0.000267	0.00105	CcSEcCtD
Dicyclomine—Somnolence—Topiramate—migraine	0.000267	0.00105	CcSEcCtD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000266	0.00246	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000265	0.00245	CbGpPWpGaD
Dicyclomine—Dyspepsia—Topiramate—migraine	0.000264	0.00104	CcSEcCtD
Dicyclomine—Hypersensitivity—Gabapentin—migraine	0.000263	0.00104	CcSEcCtD
Dicyclomine—Decreased appetite—Topiramate—migraine	0.000261	0.00103	CcSEcCtD
Dicyclomine—CHRM2—G alpha (i) signalling events—HTR1A—migraine	0.00026	0.00241	CbGpPWpGaD
Dicyclomine—Gastrointestinal disorder—Topiramate—migraine	0.000259	0.00102	CcSEcCtD
Dicyclomine—Fatigue—Topiramate—migraine	0.000259	0.00102	CcSEcCtD
Dicyclomine—Pain—Topiramate—migraine	0.000256	0.00101	CcSEcCtD
Dicyclomine—Constipation—Topiramate—migraine	0.000256	0.00101	CcSEcCtD
Dicyclomine—Asthenia—Gabapentin—migraine	0.000256	0.00101	CcSEcCtD
Dicyclomine—Nausea—Valproic Acid—migraine	0.000255	0.00101	CcSEcCtD
Dicyclomine—CHRM1—GPCR ligand binding—HTR2B—migraine	0.000254	0.00236	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000254	0.00235	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR2B—migraine	0.000253	0.00235	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000253	0.00235	CbGpPWpGaD
Dicyclomine—Dizziness—Timolol—migraine	0.000253	0.000999	CcSEcCtD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—BDNF—migraine	0.000253	0.00234	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—HTR7—migraine	0.000253	0.00234	CbGpPWpGaD
Dicyclomine—Pruritus—Gabapentin—migraine	0.000252	0.000995	CcSEcCtD
Dicyclomine—CHRM2—GPCR ligand binding—HTR2B—migraine	0.000251	0.00233	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000251	0.00232	CbGpPWpGaD
Dicyclomine—Feeling abnormal—Topiramate—migraine	0.000247	0.000975	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Topiramate—migraine	0.000245	0.000967	CcSEcCtD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000244	0.00226	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000244	0.00226	CbGpPWpGaD
Dicyclomine—Vomiting—Timolol—migraine	0.000243	0.00096	CcSEcCtD
Dicyclomine—Rash—Timolol—migraine	0.000241	0.000952	CcSEcCtD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000241	0.00224	CbGpPWpGaD
Dicyclomine—Dermatitis—Timolol—migraine	0.000241	0.000951	CcSEcCtD
Dicyclomine—Headache—Timolol—migraine	0.00024	0.000946	CcSEcCtD
Dicyclomine—Urticaria—Topiramate—migraine	0.000238	0.00094	CcSEcCtD
Dicyclomine—Abdominal pain—Topiramate—migraine	0.000237	0.000935	CcSEcCtD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000236	0.00219	CbGpPWpGaD
Dicyclomine—Dizziness—Gabapentin—migraine	0.000236	0.00093	CcSEcCtD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000235	0.00218	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000233	0.00216	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00023	0.00213	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000229	0.00212	CbGpPWpGaD
Dicyclomine—Nausea—Timolol—migraine	0.000227	0.000897	CcSEcCtD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000227	0.0021	CbGpPWpGaD
Dicyclomine—Vomiting—Gabapentin—migraine	0.000227	0.000894	CcSEcCtD
Dicyclomine—Rash—Gabapentin—migraine	0.000225	0.000887	CcSEcCtD
Dicyclomine—Dermatitis—Gabapentin—migraine	0.000225	0.000886	CcSEcCtD
Dicyclomine—Headache—Gabapentin—migraine	0.000223	0.000881	CcSEcCtD
Dicyclomine—Hypersensitivity—Topiramate—migraine	0.000221	0.000872	CcSEcCtD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000218	0.00202	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000217	0.00201	CbGpPWpGaD
Dicyclomine—Asthenia—Topiramate—migraine	0.000215	0.000849	CcSEcCtD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000215	0.00199	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—HTR2A—migraine	0.000214	0.00198	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CALCRL—migraine	0.000213	0.00197	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—RAMP1—migraine	0.000213	0.00197	CbGpPWpGaD
Dicyclomine—Pruritus—Topiramate—migraine	0.000212	0.000837	CcSEcCtD
Dicyclomine—CHRM3—GPCR downstream signaling—CALCRL—migraine	0.000212	0.00196	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—RAMP1—migraine	0.000212	0.00196	CbGpPWpGaD
Dicyclomine—Nausea—Gabapentin—migraine	0.000212	0.000835	CcSEcCtD
Dicyclomine—CHRM2—GPCR downstream signaling—RAMP1—migraine	0.00021	0.00195	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CALCRL—migraine	0.00021	0.00195	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000209	0.00194	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000209	0.00193	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000207	0.00192	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000207	0.00192	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000206	0.00191	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000206	0.00191	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000206	0.00191	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000206	0.0019	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000206	0.0019	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000204	0.00189	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000204	0.00189	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000204	0.00189	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000202	0.00187	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000202	0.00187	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.0002	0.00185	CbGpPWpGaD
Dicyclomine—Dizziness—Topiramate—migraine	0.000198	0.000782	CcSEcCtD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000197	0.00182	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000196	0.00182	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000196	0.00182	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—migraine	0.000196	0.00182	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000194	0.0018	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CALCRL—migraine	0.000193	0.00179	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—RAMP1—migraine	0.000193	0.00179	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CALCRL—migraine	0.000193	0.00178	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—RAMP1—migraine	0.000193	0.00178	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—RAMP1—migraine	0.000191	0.00177	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CALCRL—migraine	0.000191	0.00177	CbGpPWpGaD
Dicyclomine—Vomiting—Topiramate—migraine	0.000191	0.000752	CcSEcCtD
Dicyclomine—Rash—Topiramate—migraine	0.000189	0.000746	CcSEcCtD
Dicyclomine—Dermatitis—Topiramate—migraine	0.000189	0.000745	CcSEcCtD
Dicyclomine—Headache—Topiramate—migraine	0.000188	0.000741	CcSEcCtD
Dicyclomine—CHRM1—G alpha (q) signalling events—HTR2A—migraine	0.000187	0.00174	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—HTR2A—migraine	0.000187	0.00173	CbGpPWpGaD
Dicyclomine—Nausea—Topiramate—migraine	0.000178	0.000703	CcSEcCtD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000177	0.00164	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000177	0.00164	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000175	0.00162	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000168	0.00155	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000167	0.00155	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HTR1B—migraine	0.000166	0.00154	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR1B—migraine	0.000165	0.00153	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HTR1B—migraine	0.000164	0.00152	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HTR1A—migraine	0.000159	0.00148	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR1A—migraine	0.000159	0.00147	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HTR1A—migraine	0.000157	0.00146	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—TAC1—migraine	0.000157	0.00146	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—NPS—migraine	0.000157	0.00146	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—NPS—migraine	0.000157	0.00145	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—TAC1—migraine	0.000157	0.00145	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—NPS—migraine	0.000155	0.00144	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—TAC1—migraine	0.000155	0.00144	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR1D—migraine	0.000155	0.00143	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR1D—migraine	0.000154	0.00143	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HTR2C—migraine	0.000154	0.00143	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR2C—migraine	0.000154	0.00142	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR1D—migraine	0.000153	0.00141	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HTR2C—migraine	0.000152	0.00141	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—EDNRA—migraine	0.00015	0.00139	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—EDNRA—migraine	0.000149	0.00138	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—EDNRA—migraine	0.000148	0.00137	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000145	0.00134	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000144	0.00134	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—CALCA—migraine	0.000144	0.00134	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—CALCA—migraine	0.000144	0.00133	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR2B—migraine	0.000144	0.00133	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR2B—migraine	0.000143	0.00133	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000143	0.00132	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—CALCA—migraine	0.000142	0.00132	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR2B—migraine	0.000142	0.00131	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR1D—migraine	0.00014	0.0013	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR1D—migraine	0.00014	0.0013	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR1D—migraine	0.000139	0.00128	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HTR7—migraine	0.000135	0.00125	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR7—migraine	0.000134	0.00125	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HTR7—migraine	0.000133	0.00123	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR2B—migraine	0.00013	0.00121	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR2B—migraine	0.00013	0.0012	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR2B—migraine	0.000129	0.00119	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000124	0.00115	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000124	0.00115	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000122	0.00113	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RAMP1—migraine	0.000114	0.00106	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CALCRL—migraine	0.000114	0.00106	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RAMP1—migraine	0.000114	0.00105	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CALCRL—migraine	0.000114	0.00105	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RAMP1—migraine	0.000113	0.00104	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CALCRL—migraine	0.000113	0.00104	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CACNA1A—migraine	0.000103	0.000955	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HTR2A—migraine	9.45e-05	0.000875	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR2A—migraine	9.42e-05	0.000873	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR1B—migraine	9.36e-05	0.000868	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR1B—migraine	9.33e-05	0.000865	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HTR2A—migraine	9.33e-05	0.000864	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR1B—migraine	9.24e-05	0.000856	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—TNF—migraine	9.2e-05	0.000852	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR1A—migraine	9.01e-05	0.000835	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR1A—migraine	8.98e-05	0.000832	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR1A—migraine	8.9e-05	0.000824	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—TAC1—migraine	8.88e-05	0.000822	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—NPS—migraine	8.88e-05	0.000822	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—TAC1—migraine	8.85e-05	0.00082	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—NPS—migraine	8.85e-05	0.00082	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—TAC1—migraine	8.76e-05	0.000812	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—NPS—migraine	8.76e-05	0.000812	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR2C—migraine	8.71e-05	0.000806	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR2C—migraine	8.68e-05	0.000804	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR2C—migraine	8.59e-05	0.000796	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR1B—migraine	8.5e-05	0.000788	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR1B—migraine	8.48e-05	0.000785	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—EDNRA—migraine	8.47e-05	0.000785	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—EDNRA—migraine	8.44e-05	0.000782	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR1B—migraine	8.39e-05	0.000778	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—EDNRA—migraine	8.36e-05	0.000774	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR1D—migraine	8.29e-05	0.000768	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR1D—migraine	8.26e-05	0.000766	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CACNA1A—migraine	8.19e-05	0.000759	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR1A—migraine	8.19e-05	0.000758	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR1D—migraine	8.18e-05	0.000758	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR1A—migraine	8.16e-05	0.000756	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CALCA—migraine	8.15e-05	0.000755	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CALCA—migraine	8.13e-05	0.000753	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR1A—migraine	8.08e-05	0.000749	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—NPS—migraine	8.06e-05	0.000747	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—TAC1—migraine	8.06e-05	0.000747	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CALCA—migraine	8.05e-05	0.000745	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—TAC1—migraine	8.04e-05	0.000744	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—NPS—migraine	8.04e-05	0.000744	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—TAC1—migraine	7.96e-05	0.000737	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—NPS—migraine	7.96e-05	0.000737	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR2C—migraine	7.91e-05	0.000732	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR2C—migraine	7.88e-05	0.00073	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR2C—migraine	7.8e-05	0.000723	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2B—migraine	7.71e-05	0.000714	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EDNRA—migraine	7.69e-05	0.000712	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2B—migraine	7.68e-05	0.000712	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EDNRA—migraine	7.67e-05	0.00071	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR7—migraine	7.62e-05	0.000706	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2B—migraine	7.61e-05	0.000705	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR7—migraine	7.6e-05	0.000704	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EDNRA—migraine	7.59e-05	0.000703	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR7—migraine	7.53e-05	0.000697	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CALCA—migraine	7.4e-05	0.000686	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CALCA—migraine	7.38e-05	0.000684	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CALCA—migraine	7.31e-05	0.000677	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR7—migraine	6.92e-05	0.000641	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR7—migraine	6.9e-05	0.000639	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR7—migraine	6.83e-05	0.000633	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LRP1—migraine	6.79e-05	0.000629	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LRP1—migraine	6.76e-05	0.000627	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LRP1—migraine	6.7e-05	0.000621	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR2A—migraine	5.34e-05	0.000495	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR2A—migraine	5.32e-05	0.000493	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR2A—migraine	5.27e-05	0.000488	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH4—migraine	5.21e-05	0.000482	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH4—migraine	5.19e-05	0.000481	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH4—migraine	5.14e-05	0.000476	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR1B—migraine	5.02e-05	0.000465	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR1B—migraine	5.01e-05	0.000464	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR1B—migraine	4.96e-05	0.000459	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR2A—migraine	4.85e-05	0.000449	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR1A—migraine	4.84e-05	0.000448	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR2A—migraine	4.83e-05	0.000448	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR1A—migraine	4.82e-05	0.000447	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR2A—migraine	4.79e-05	0.000443	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR1A—migraine	4.77e-05	0.000442	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TAC1—migraine	4.76e-05	0.000441	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PGR—migraine	4.76e-05	0.000441	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NPS—migraine	4.76e-05	0.000441	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NPS—migraine	4.75e-05	0.00044	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PGR—migraine	4.75e-05	0.00044	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TAC1—migraine	4.75e-05	0.00044	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NPS—migraine	4.7e-05	0.000435	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TAC1—migraine	4.7e-05	0.000435	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PGR—migraine	4.7e-05	0.000435	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2C—migraine	4.67e-05	0.000433	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2C—migraine	4.65e-05	0.000431	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2C—migraine	4.61e-05	0.000427	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EDNRA—migraine	4.54e-05	0.000421	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDNRA—migraine	4.53e-05	0.00042	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDNRA—migraine	4.48e-05	0.000415	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH3—migraine	4.43e-05	0.00041	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH3—migraine	4.41e-05	0.000409	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CALCA—migraine	4.37e-05	0.000405	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH3—migraine	4.37e-05	0.000405	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CALCA—migraine	4.36e-05	0.000404	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CALCA—migraine	4.32e-05	0.0004	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR7—migraine	4.09e-05	0.000379	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR7—migraine	4.08e-05	0.000378	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR7—migraine	4.04e-05	0.000374	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFBR2—migraine	3.52e-05	0.000326	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFBR2—migraine	3.51e-05	0.000325	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFBR2—migraine	3.48e-05	0.000322	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—migraine	3.41e-05	0.000316	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2A—migraine	2.86e-05	0.000265	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2A—migraine	2.86e-05	0.000265	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2A—migraine	2.83e-05	0.000262	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—migraine	2.71e-05	0.000251	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ESR1—migraine	2.54e-05	0.000236	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ESR1—migraine	2.53e-05	0.000235	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ESR1—migraine	2.51e-05	0.000233	CbGpPWpGaD
